Friday 6 November 2026 Export IRTC’s income statement to Excel — free account

iRhythm Holdings, Inc.

iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.

Revenue: +14.9%
EPS: −462.5%
Free cash flow: −157.6%
Total debt: +0.48%

Quarter to September 2026, against a year earlier

90.26 39.93 −30.67%

Follow IRTC

Alert me

Market cap: $4.3B
P/E: 0.0×
Fwd P/E: −311×
Dividend yield: —
F-score: 5/9
Altman Z: 4.02
Beneish M: −3.04
Dividend safety: n/a

Overview

iRhythm Holdings, Inc. (IRTC) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, iRhythm Holdings, Inc. (IRTC) trades at a P/S ratio of 5.1×. Over the past ten years it has ranged from 0.6× (November 2016) to 29.8× (November 2020); the current reading is higher than 17% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IRTC/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="iRhythm Holdings, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IRTC/metrics/ps-ratio">iRhythm Holdings, Inc. (IRTC) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	7.6×	59.92%
FY2024	4.8×	(24.31%)
FY2023	6.3×	(8.32%)
FY2022	6.8×	(35.95%)
FY2021	10.7×	(56.93%)
FY2020	24.8×	209.64%
FY2019	8.0×	(28.84%)
FY2018	11.3×	(14.26%)
FY2017	13.1×	431.21%
FY2016	2.5×	257.39%

Period	P/S ratio	Change
Sep 2026	4.4×	(7.09%)
Jun 2026	4.7×	(2.64%)
Mar 2026	4.9×	(35.93%)
Dec 2025	7.6×	(3.49%)
40 more quarters	Free account

Against its own ten years

Low 0.6× High 29.8×

Ten-year median 8.8×

Current reading's percentile 17

Company	P/S ratio
ITGR Integer Holdings Corporation compare	2.4×
NEOG Neogen Corporation compare	2.9×
TMDX TransMedics Group, Inc. compare	3.3×
LIVN LivaNova PLC compare	3.4×
UFPT UFP Technologies, Inc. compare	3.6×
HAE Haemonetics Corporation compare	4.1×
IRTC iRhythm Holdings, Inc.	5.1×
AXGN AxoGen, Inc. compare	10.1×
TXG 10x Genomics compare	12.4×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

iRhythm Holdings, Inc. (IRTC) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IRTC

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IRTC

Stockrow Weekly